WOAG
WITHDRAWAL OF ATTORNEY GRANTED
14/09/2023
Voltar para busca
Dado oficial do USPTO
CANNAFEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
49
Atualização mais recente
24/09/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10
Data de depósito
05/10/2018
Data de registro
16/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/06/2020
Última transação
24/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
BEN, LINDSEY
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Senzer Limited
Representantes
Senzer Limited
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for inhalers for the treatment of painneuropathyasthmachronic obstructive pulmonary disease (copd)bronchitisemphysemaepilepsyanxietydepressionParkinson's diseaseHuntington's diseasesamyotrophic lateral sclerosisnauseastrokecancerdrug dependenceglaucomaautoimmune uveitisbacterial and fungal infectionsosteoporosissepsishepaticrenalintestinal and cardiovascular disorders; pharmaceutical preparations and substances for use in chemotherapy; pharmaceutical preparations for inhalers for the treatment of painneuropathyasthmachronic obstructive pulmonary disease (copd)bronchitisemphysemaepilepsyanxietydepressionParkinson's diseaseHuntington's diseasesamyotrophic lateral sclerosisnauseastrokecancerdrug dependenceglaucomaautoimmune uveitisbacterial and fungal infectionsosteoporosissepsishepaticrenalintestinal and cardiovascular disorders; drug delivery agents in the nature of tabletsliquid medicationsinhalersnasal and oral sprays that facilitate the delivery of a wide range of pharmaceuticals; Transdermal patches and transdermal patches for medical treatmentboth for the treatment of painneuropathyasthmachronic obstructive pulmonary disease (copd)bronchitisemphysemaepilepsyanxietydepressionParkinson's diseaseHuntington's diseasesamyotrophic lateral sclerosisnauseastrokecancerdrug dependenceglaucomaautoimmune uveitisbacterial and fungal infectionsosteoporosissepsishepaticrenalintestinal and cardiovascular disorders; all of the aforementioned goods containing cannabis that is solely synthetic in nature; sanitary preparations for medical purposesvaccinessanitary sterilising preparationsall not containing cannabis or CBD
Classe 10
Inhalers for medical purposes; medical inhalers; inhalers for medical use; inhalers for therapeutic use; therapeutic inhalers; inhalers for medical purposessold empty; all of the aforementioned goods either exclusively for use with cannabis that is solely synthetic in naturecontaining cannabis that is solely synthetic in nature
Publicações
Histórico de despachos e eventos da marca no USPTO.
49 publicações encontradas
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
14/09/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/01/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/10/2020
FIMP
FINAL DISPOSITION PROCESSED
04/10/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/09/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
16/06/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
15/05/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/04/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
29/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/03/2020
PUBO
PUBLISHED FOR OPPOSITION
31/03/2020
GPNX
NOTIFICATION PROCESSED BY IB
27/03/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/03/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/03/2020
ALIE
ASSIGNED TO LIE
27/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/02/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
21/02/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/02/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
21/02/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/01/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/07/2019
GNRT
NON-FINAL ACTION E-MAILED
23/07/2019
CNRT
NON-FINAL ACTION WRITTEN
23/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/06/2019
RFNT
REFUSAL PROCESSED BY IB
21/06/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/05/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/05/2019
GNRT
NON-FINAL ACTION E-MAILED
20/05/2019
CNRT
NON-FINAL ACTION WRITTEN
20/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/04/2019
RFNT
REFUSAL PROCESSED BY IB
17/01/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/12/2018
RFRR
REFUSAL PROCESSED BY MPU
29/12/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/12/2018
CNRT
NON-FINAL ACTION WRITTEN
17/12/2018
DOCK
ASSIGNED TO EXAMINER
12/12/2018
DOCK
ASSIGNED TO EXAMINER
11/12/2018
MAFR
APPLICATION FILING RECEIPT MAILED
04/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/11/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/11/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CANNAFEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.